Nurix

Updated: August 05, 2025

Co-Founder John Kuriyan

Country: USA | Funding: $545.9M (+)

Website: https://www.nurixtx.com/

Nurix develops small molecule inhibitors for the treatment of proliferative and degenerative diseases.

Competitors